Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAmortizatization of IntangiblesAmortizatization of IntangiblesCash from Financing ActivitiesCash from Financing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Growth Metrics
Income Statement
Others
Ratios

Spectral AI (MDAIW) Cash from Investing Activities (2021 - 2022)

Spectral AI posted quarterly Cash from Investing Activities of $251.2 million for Q4 2022, up 199.29% on a QoQ basis from -$253.0 million in Q1 2021.

Spectral AI (MDAIW) has 2 years of Cash from Investing Activities data on file, last reported at $251.2 million in Q4 2022.

  • For the quarter ending Q4 2022, Cash from Investing Activities changed N/A year-over-year to $251.2 million; the trailing twelve-month figure through Dec 2022 stood at $251.2 million (up 199.29% YoY), and the FY2022 full-year result was $251.6 million, up 199.43% from the prior year.
  • Cash from Investing Activities for Q4 2022 stood at $251.2 million, up from -$253.0 million in the prior quarter.
  • Across five years, Cash from Investing Activities topped out at $251.2 million in Q4 2022 and bottomed at -$253.0 million in Q1 2021.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Investing Activities (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn -20.32 Bn
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn -185.00 Mn
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn -816.00 Mn
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn -591.00 Mn
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn -92.80 Mn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn -475.32 Mn
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn -298.50 Mn
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn -2.50 Bn
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn -217.20 Mn
10 Spectral AI - - 2.03 Mn -

Historic Data

Download Data 🔒
DateValue
Dec 31, 2022 251.21 Mn
Dec 31, 2022 251.21 Mn
Mar 31, 2021 -253.00 Mn
Mar 31, 2021 -253.00 Mn